Published in Haematologica on January 06, 2010
Study on the Clinical Course Of Pulmonary Embolism (SCOPE) | NCT01781858
Chronic thromboembolic pulmonary hypertension. Neth Heart J (2014) 1.18
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res (2015) 1.07
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J (2010) 0.92
Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series). Pulm Circ (2014) 0.90
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Postepy Kardiol Interwencyjnej (2015) 0.89
Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy. Pulm Circ (2012) 0.83
Venous thromboembolism and subsequent permanent work-related disability. J Thromb Haemost (2016) 0.82
Coagulation and the vessel wall in pulmonary embolism. Pulm Circ (2013) 0.79
Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension. Pulm Circ (2016) 0.79
Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism. J Thromb Thrombolysis (2015) 0.78
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries. BMC Health Serv Res (2014) 0.78
Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. J Thorac Dis (2015) 0.78
2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.77
Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension. Eur Radiol (2016) 0.77
Long-term prognosis and related factors towards patients with acute pulmonary thromboembolism. Int J Clin Exp Med (2015) 0.77
Pulmonary flow profile and distensibility following acute pulmonary embolism. J Cardiovasc Magn Reson (2011) 0.76
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study. J Thromb Thrombolysis (2016) 0.75
Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension. Pulm Circ (2015) 0.75
The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism. Diagn Interv Radiol (2015) 0.75
Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms. Methodist Debakey Cardiovasc J (2017) 0.75
An elderly man with pulmonary hypertension. Ann Thorac Med (2011) 0.75
A symptom-related monitoring program following pulmonary embolism for the early detection of CTEPH: a prospective observational registry study. BMC Pulm Med (2014) 0.75
Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. Heart Fail Rev (2016) 0.75
Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences. Respir Med Case Rep (2017) 0.75
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med (2004) 5.68
Chronic thromboembolic pulmonary hypertension. N Engl J Med (2001) 3.51
Chronic thromboembolic pulmonary hypertension. Circulation (2006) 2.58
Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J (2000) 2.31
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest (2006) 1.85
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol (2008) 1.69
Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) (2006) 1.38
Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology (1992) 1.27
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost (2005) 1.17
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res (2009) 1.07
Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr (2006) 1.01
Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J (2008) 1.00
Diagnostic management of clinically suspected acute pulmonary embolism. J Thromb Haemost (2009) 0.90
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med (2008) 6.00
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA (2006) 4.75
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med (2007) 2.88
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation (2006) 2.54
Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J (2008) 2.51
MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One (2009) 2.49
Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation (2007) 2.31
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med (2011) 2.28
The value of 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur J Nucl Med Mol Imaging (2013) 2.13
Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J (2013) 2.09
Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy. J Rheumatol (2012) 2.04
Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol (2007) 2.00
Impaired cardiac reserve in asymptomatic patients with moderate pulmonary restenosis late after relief of severe pulmonary stenosis: evidence for diastolic dysfunction. Int J Cardiol (2012) 1.99
A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab (2010) 1.98
Gender and outcome in adult congenital heart disease. Circulation (2008) 1.90
Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol (2011) 1.87
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA (2005) 1.87
Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med (2003) 1.83
Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol (2007) 1.81
Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J (2013) 1.76
Detection of vein graft disease using high-resolution magnetic resonance angiography. Circulation (2002) 1.76
Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol (2004) 1.72
Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur Heart J (2005) 1.71
Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med (2008) 1.71
EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy. Lung Cancer (2008) 1.69
Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J (2007) 1.68
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thromb Haemost (2008) 1.64
Right ventricular function in patients with acute pulmonary embolism: analysis with electrocardiography-synchronized multi-detector row CT. Radiology (2006) 1.63
Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation (2013) 1.60
Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J (2010) 1.57
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension. Eur Respir J (2012) 1.55
Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology (2005) 1.54
Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation (2012) 1.54
D-dimer testing in patients with suspected pulmonary embolism and impaired renal function. Am J Med (2009) 1.53
Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test. Am J Med (2002) 1.53
Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood (2013) 1.51
Employment in adults with congenital heart disease. Arch Pediatr Adolesc Med (2002) 1.50
Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies. J Clin Oncol (2008) 1.49
Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J (2006) 1.49
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care (2004) 1.46
[Suspicion of pulmonary embolism: added value of CT depends on patient characteristics and referring individual]. Ned Tijdschr Geneeskd (2012) 1.45
Hemodynamic evaluation of saphenous vein coronary artery bypass grafts: relative merits of Doppler flow velocity and SPECT perfusion imaging. J Nucl Cardiol (2005) 1.41
Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J (2007) 1.40
Mortality in adult congenital heart disease. Eur Heart J (2010) 1.40
Mild residual pulmonary stenosis in tetralogy of fallot reduces risk of pulmonary valve replacement. Ann Thorac Surg (2012) 1.39
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet (2008) 1.39
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran. Thromb Haemost (2015) 1.36
Right ventricular function after pulmonary valve replacement in patients with tetralogy of Fallot. Radiology (2004) 1.31
18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med (2010) 1.27
Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med (2008) 1.24
Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. J Clin Oncol (2008) 1.23
Feasibility of assessment of coronary stent patency using 16-slice computed tomography. Am J Cardiol (2004) 1.20
Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial. Eur Heart J (2011) 1.17
Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension. Circ Cardiovasc Imaging (2012) 1.17
Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med (2002) 1.14
Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med (2009) 1.13
Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol (2005) 1.12
The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. Chest (2007) 1.12
Intra-observer and interobserver variability of biventricular function, volumes and mass in patients with congenital heart disease measured by CMR imaging. Int J Cardiovasc Imaging (2009) 1.09
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thromb Res (2007) 1.08
VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb Haemost (2009) 1.07
Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest (2006) 1.05
Comprehensive assessment of patients after coronary artery bypass grafting by 16-detector-row computed tomography. Am Heart J (2005) 1.05
Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J (2012) 1.04
Quality of life in long-term survivors of acute pulmonary embolism. Chest (2010) 1.04
Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol (2010) 1.03
Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology (2005) 1.03
Association of aortic arch pulse wave velocity with left ventricular mass and lacunar brain infarcts in hypertensive patients: assessment with MR imaging. Radiology (2009) 1.02
Time course of diastolic and systolic function improvement after pulmonary valve replacement in adult patients with tetralogy of Fallot. J Am Coll Cardiol (2005) 1.02
Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol (2011) 1.02
Global and regional left ventricular function assessment with 16-detector row CT: comparison with echocardiography and cardiovascular magnetic resonance. Eur J Echocardiogr (2005) 1.01
Computed tomography pulmonary angiography as a single imaging test to rule out pulmonary embolism. Curr Opin Pulm Med (2011) 1.01
Predicting outcome of pulmonary valve replacement in adult tetralogy of Fallot patients. Ann Thorac Surg (2007) 1.00
Normal limits of the spatial QRS-T angle and ventricular gradient in 12-lead electrocardiograms of young adults: dependence on sex and heart rate. J Electrocardiol (2008) 1.00
Long-term effect of pulmonary valve replacement on QRS duration in patients with corrected tetralogy of Fallot. Heart (2006) 0.99
Mediastinal-esophageal fistulae after EUS-FNA of tuberculosis of the mediastinum. Gastrointest Endosc (2009) 0.98
Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol (2003) 0.98
Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease. Int J Cardiol (2011) 0.97
Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost (2012) 0.97